HeartFlow recently filed a Form S-1 with the SEC to confirm its intent to complete an initial public offering (IPO) and go ...

A court sided with Medtronic (NYSE:MDT), overturning a 2023 verdict ordering the medtech giant to pay a significant amount in ...

Boston Scientific has received expanded FDA approval for the use of its Watchman FLX and Watchman FLX Pro devices.

ZimVie has agreed to be acquired by an affiliate of the healthcare investment firm Archimed for $19 a share in cash.

CEO Daniel Scavilla has resigned to take over the corner office at Dentsply Sirona, the companies announced today.

RadNet today announced it completed the purchase of iCAD, adding the breast-imaging AI developer to RadNet’s DeepHealth ...

Hyperfine (Nasdaq:HYPR) announced that it made the first commercial sales of its next-generation Swoop system powered by new ...

Exactech today announced it appointed Dr. Richard J. Friedman as chief medical officer, effective immediately.

Nuwellis terminated its REVERSE‑HF randomized trial comparing ultrafiltration with IV loop diuretics in hospitalized heart ...

Stereotaxis announced that it entered into definitive agreements with investors to sell approximately $12.5 million in common stock.

NanoVibronix (Nasdaq:NAOV) today announced that it entered into a definitive agreement to sell up to $50 million in stock.

UroMems received FDA investigational device exemption (IDE) approval to begin a first-of-its-kind trial for its smart implant ...